Conclusions: A beneficial effect on the level of TOS/TOC and CAT activity was indicated, but the proposed number of treatments for patients with class II obesity turned out to be insufficient. The gene discussed is CAT; the disease is obesity due to melanocortin 4 receptor deficiency.